Israel has announced a drug that shows effectiveness against Covid-19 in patients considered to be serious. The drug, which is inhaled, was tested in 30 critically ill patients, 29 of whom were discharged in less than five days.
Israeli doctor Nadir Arber successfully completed a phase 1 clinical trial with a treatment for covid-19, a drug, Exo-CD24, applied by inhaling a few minutes for five consecutive days.
The news advanced by SIC, reveals that the new product, based on exosomes enriched with CD24, is administered directly to the lungs. The goal is to end the cytokine storm caused by coronavirus infection.
The drug was applied to 30 Covid patients, the largest one without speech power and with breathing difficulties. Of all the patients, there was one that took longer to recover. However, 29 recovered their strength and within three to five days returned home, reports the SIC Notícias report.
Ichilov Hospital prepared a report on the patients investigated. It was referred to the Israeli Ministry of Health to be regulated.
The SIC report is by SIC correspondent in the Middle East, Henrique Cymerman.
We recall that this new treatment for Covid-19 developed at the Ichilov Medical Center in Tel Aviv, Israel, according to the news published by diariOnline South Region citing TVI24, on February 5, it successfully concluded the first phase tests.